Amarin Corp. Plc (AMRN)
12.35
-0.37
(-2.91%)
USD |
NASDAQ |
Oct 02, 16:00
12.38
+0.02
(+0.20%)
After-Hours: 20:00
Amarin Net Income (Quarterly) : -7.664M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.664M |
| March 31, 2026 | -10.49M |
| December 31, 2025 | -1.222M |
| September 30, 2025 | -7.690M |
| June 30, 2025 | -14.31M |
| March 31, 2025 | -15.76M |
| December 31, 2024 | -48.17M |
| September 30, 2024 | -25.39M |
| June 30, 2024 | 1.524M |
| March 31, 2024 | -9.947M |
| December 31, 2023 | -5.831M |
| September 30, 2023 | -19.20M |
| June 30, 2023 | -17.62M |
| March 31, 2023 | -16.61M |
| December 31, 2022 | 0.8624M |
| September 30, 2022 | -5.096M |
| June 30, 2022 | -69.35M |
| March 31, 2022 | -31.38M |
| December 31, 2021 | 14.72M |
| September 30, 2021 | -13.09M |
| June 30, 2021 | 7.793M |
| March 31, 2021 | -1.632M |
| December 31, 2020 | 4.968M |
| September 30, 2020 | -6.910M |
| June 30, 2020 | 4.426M |
| Date | Value |
|---|---|
| March 31, 2020 | -20.57M |
| December 31, 2019 | 7.164M |
| September 30, 2019 | -3.440M |
| June 30, 2019 | -1.811M |
| March 31, 2019 | -24.69M |
| December 31, 2018 | -33.39M |
| September 30, 2018 | -24.51M |
| June 30, 2018 | -33.79M |
| March 31, 2018 | -24.26M |
| December 31, 2017 | -22.77M |
| September 30, 2017 | -10.89M |
| June 30, 2017 | -13.91M |
| March 31, 2017 | -20.03M |
| December 31, 2016 | -25.03M |
| September 30, 2016 | -14.53M |
| June 30, 2016 | -12.77M |
| March 31, 2016 | -27.97M |
| December 31, 2015 | -21.76M |
| September 30, 2015 | -30.53M |
| June 30, 2015 | -30.89M |
| March 31, 2015 | -29.14M |
| December 31, 2014 | -19.56M |
| September 30, 2014 | -26.19M |
| June 30, 2014 | 16.00M |
| March 31, 2014 | -27.15M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Neurocrine Biosciences, Inc. | 144.40M |
| Alkermes Plc | 0.501M |
| Liquidia Corp. | 74.72M |
| Akari Therapeutics Plc | -4.816M |
| DBV Technologies SA | -- |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 42.29M |
| Total Expenses (Quarterly) | 49.95M |
| EPS Diluted (Quarterly) | -0.3681 |
| Enterprise Value | -50.22M |
| Gross Profit Margin (Quarterly) | 34.00% |
| Profit Margin (Quarterly) | -18.12% |
| Earnings Yield | -10.51% |
| Normalized Earnings Yield | -5.944 |